1. Home
  2. News Archive

More News

BVI Opens Experience Hub for Ophthalmic Training, Collaboration
BVI Opens Experience Hub for Ophthalmic Training, Collaboration

BVI Medical, of Waltham, Massachusetts, announced June 15 that it had opened a new BVI Experience Hub within its offices in Sant Cugat, Spain. The hub is designed to support ophthalmic training and...

Braille Institute Names Six Recipients of Community Hero Awards
Braille Institute Names Six Recipients of Community Hero Awards

The Braille Institute of America honored six recipients of its Community Hero Awards at a dinner on June 25. The awards recognize extraordinary organizations and leaders for breaking barriers, expa...

Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking
Vermont Expands ODs’ Scope to Include SLT, LPI, YAG Capsulotomy, Crosslinking

Vermont has become the 17th US state to pass a law expanding optometrists’ scope of practice to include in-office laser procedures. Senate Bill 64, signed into law by Gov. Phil Scott on June 18, gr...

Théa Pharma Launches Zolymbus Bimatoprost Gel for Glaucoma in the US
Théa Pharma Launches Zolymbus Bimatoprost Gel for Glaucoma in the US

Théa Pharma, the Massachusetts-based subsidiary of France-based Théa, announced June 15 that it had launched Zolymbus (bimatoprost ophthalmic gel) 0.01% in the US. Thepreservative-free formulation ...

Hexiris Showcases Glaucoma Devices Targeting Office-Based Surgery
Hexiris Showcases Glaucoma Devices Targeting Office-Based Surgery

Canada’s Hexiris Ophthalmics reports that it is showcasing at ophthalmic meetings its glaucoma device candidates targeting office-based surgery, with an eye toward a commercial launch in 2026. Surg...

EBAA Annual Meeting Underlines Human Impact of Donation
EBAA Annual Meeting Underlines Human Impact of Donation

The 2026 Eye Bank Association of America (EBAA) annual meeting brought together approximately 250 eye bank technicians, medical directors, corneal surgeons, and industry professionals June 3-6 in I...

Formosa Licenses Clobetasol Drops to Samil for Vietnam
Formosa Licenses Clobetasol Drops to Samil for Vietnam

Taiwan-based Formosa Pharmaceuticals announced June 11 that it had expanded its licensing agreement with Samil Pharmaceuticals for clobetasol propionate 0.05% eye drops for postsurgical inflammatio...

Scope Health Adds Vision Support and Eye Comfort Eyetamins to its Optase Product Line
Scope Health Adds Vision Support and Eye Comfort Eyetamins to its Optase Product Line

Scope Health, of New York, announced June 17 that it had added Eyetamins Vision Support and Eye Comfort versions to its Optase line of eyelid hygiene and ocular lubricant products. The Eye Comfort ...

Ocusoft Introduces Retaine Ultra PF Preservative-Free Artificial Tears
Ocusoft Introduces Retaine Ultra PF Preservative-Free Artificial Tears

Ocusoft, of Rosenberg, Texas, announced on June 17 the launch of Retaine Ultra PF, a lubricating eye drop available in a preservative-free multi-dose bottle. Its active ingredients include polyethy...

Essential Pharma Appoints Becki Morison as Chief Executive Officer
Essential Pharma Appoints Becki Morison as Chief Executive Officer

UK-based Essential Pharma announced June 18 that it had appointed Becki Morison as chief executive officer, effective July 1. Morison succeeds Simon Ball, who has served as interim CEO since Novemb...

Aier Eye Hospital Group to Buy 25 VisuMax 800 Lasers from Zeiss
Aier Eye Hospital Group to Buy 25 VisuMax 800 Lasers from Zeiss

German company Carl Zeiss Meditec reported June 17 that the Aier Eye Hospital Group in China had agreed to buy 25 VisuMax 800 femtosecond lasers for its hospital locations starting this year. The V...

Johnson & Johnson to Invest $1 Billion in Jacksonville, Home of J&J Vision
Johnson & Johnson to Invest $1 Billion in Jacksonville, Home of J&J Vision

Johnson & Johnson reported June 15 that it would invest more than $1 billion in its Jacksonville, Florida, operations to scale US-based manufacturing, packaging, and distribution capabilities for i...

Belite Bio Completes Rolling NDA Submission for Oral Tinlarebant in Stargardt
Belite Bio Completes Rolling NDA Submission for Oral Tinlarebant in Stargardt

Belite Bio announced June 12 that it had completed its rolling new drug application (NDA) submission to the US FDA for oral tinlarebant for the treatment of Stargardt disease. The San Diego, Califo...

2026 ARVO Meeting Draws Big Attendance, Rare Snowstorm
2026 ARVO Meeting Draws Big Attendance, Rare Snowstorm

The 2026 meeting of the Association for Research in Vision and Ophthalmology (ARVO) drew 10,996 attendees, the second largest attendance to date, coming in just under the 2024 total of 11,631. The ...

J&J Expands US Rollout of Tecnis PureSee IOL
J&J Expands US Rollout of Tecnis PureSee IOL

Johnson & Johnson reported June 11 that it was expanding availability for the Tecnis PureSee IOL in the US. The lens gained US FDA approval in March 2026. The PureSee is a purely refractive extende...

Alcon Launches Unity CS Phaco System in Canada
Alcon Launches Unity CS Phaco System in Canada

Alcon announced June 15 the launch in Canada of the Unity CS phacoemulsification system for cataract surgery. Alcon said it planned to showcase the platform at the Canadian Ophthalmological Society...

Tavo Biotherapeutics Appoints Federico Grossi, MD, PhD, as CMO
Tavo Biotherapeutics Appoints Federico Grossi, MD, PhD, as CMO

Tavo Biotherapeutics, of Laguna Beach, California, announced June 2 that it had appointed Federico Grossi, MD, PhD, as chief medical officer (CMO). Grossi most recently was CMO of Unity Biotechnolo...

TearSolutions Gains Orphan, Fast Track Status for Lacripep in Neurotrophic Keratitis
TearSolutions Gains Orphan, Fast Track Status for Lacripep in Neurotrophic Keratitis

TearSolutions announced June 2 that the US FDA had granted orphan drug and fast track designations for its synthetic peptide eye drop candidate Lacripep in neurotrophic keratitis (NK). NK is a rare...

Regulatory Changes, Off-Brand Competition Reshape Ophthalmic Market in China
Regulatory Changes, Off-Brand Competition Reshape Ophthalmic Market in China

Continued change is shifting the dynamics of the ophthalmic market in China, boosting revenue growth in some sectors while slowing it in others. Changes are both regulatory and competitive. Regulat...

Ophthalmic Company Revenue Increases 3.7 Percent in First Quarter of 2026
Ophthalmic Company Revenue Increases 3.7 Percent in First Quarter of 2026

Ophthalmic manufacturer revenue in Q1-2026 totaled $11.4 billion. Revenue increased 3.7 percent from the same quarter in 2025 and decreased 2.9 percent from Q4-2025. The total includes Market Scope...

Ophthalmologists Report 4.7 Percent Decrease in Q1-2026 Procedure Volume
Ophthalmologists Report 4.7 Percent Decrease in Q1-2026 Procedure Volume

US ophthalmologists reported that ophthalmic procedures decreased 4.7 percent in Q1-2026 compared with the same quarter in 2025, according to Market Scope’s latest survey. Year-over-year performanc...

SpyGlass Gains Category III CPT Code for Its Drug-Eluting BIM-IOL System
SpyGlass Gains Category III CPT Code for Its Drug-Eluting BIM-IOL System

SpyGlass Pharma, of Aliso Viejo, California, reported May 18 that the American Medical Association had approved a new add-on Category III CPT code that will allow surgeons to be reimbursed separate...

Oculis Scraps DME Eye Drop Program after Missing Phase III Endpoints
Oculis Scraps DME Eye Drop Program after Missing Phase III Endpoints

Swiss company Oculis reported May 29 that it would not pursue US FDA approval for OCS-01, its dexametha-sone eye drop candidate targeting diabetic macular edema (DME), after the primary endpoint of...

Select US FDA Approvals and Clearances in May 2026
Select US FDA Approvals and Clearances in May 2026

The US FDA’s ophthalmic device division granted clearance to two devices using the 510(k) pathway in May 2026, according to the agency’s database. Heidelberg received clearance for its updated Spec...

PDUFA Dates for Ophthalmic Drug Candidates, June 2026
PDUFA Dates for Ophthalmic Drug Candidates, June 2026

The US FDA has scheduled the following Prescription Drug User Fee Act (PDUFA) target action dates for ophthalmic drug, drug/device, and biologic candidates.

US FDA Commissioner Makary Resigns After Rocky Year in Top Job
US FDA Commissioner Makary Resigns After Rocky Year in Top Job

US FDA Commissioner Marty Makary, MD, MPH, resigned May 12 after a rocky year in the agency’s top job that saw mass layoffs, high-level resignations, and policy fights with lawmakers, drugmakers, a...

ViaLase Announces First Commercial FLIGHT Procedures in Glaucoma Patients
ViaLase Announces First Commercial FLIGHT Procedures in Glaucoma Patients

ViaLase, of Aliso Viejo, California, announced May 26 that surgeons in London and Germany had performed the first commercial procedures using its ViaLuxe Laser System for femtosecond laser image-gu...

Ethyreal Bio Leads Latest Fundraising with $101 Million in Series A
Ethyreal Bio Leads Latest Fundraising with $101 Million in Series A

Ethyreal Bio led recent ophthalmic fundraising efforts with $101 million in a Series A financing to advance its subcutaneous candidate for thyroid eye disease. Financing announced in the past four ...

2026-2027 Ophthalmic Meetings Calendar
2026-2027 Ophthalmic Meetings Calendar

Market Scope regularly updates its list of ophthalmic meetings to keep the information current. Please contact us at matthewdouty@market-scope.com if we do not have your meeting listed. Thank you.

Eyecelerator@ARVO and All Access Saturday Look at Business Side of Developing Therapeutics
Eyecelerator@ARVO and All Access Saturday Look at Business Side of Developing Therapeutics

May 1 marked the start of a new era for Eyecelerator, the organizer of ophthalmology innovation business conferences. It was the first time Eyecelerator was officially part of ARVO (Association for...

2026 ARVO Keynote Speaker Says ‘Age of RNA’ Has Arrived
2026 ARVO Keynote Speaker Says ‘Age of RNA’ Has Arrived

Thomas Cech, PhD, declared the 21st century “the age of RNA” during his opening keynote address at the 2026 ARVO meeting. Sally Temple, PhD, used the closing keynote to talk about the future of ste...

AI Sessions at 2026 ARVO Meeting Move Past the Hype
AI Sessions at 2026 ARVO Meeting Move Past the Hype

The conversation around AI in ophthalmology has evolved over the past three years. The emphasis at the 2026 ARVO meeting and the Focus A-Eye Summit was on how to bridge the gap between innovation a...

New Blood Collection Strategies Aim to Expand Supply of Donor Tissue for Cornea Transplants
New Blood Collection Strategies Aim to Expand Supply of Donor Tissue for Cornea Transplants

Researchers at the 2026 EBAA meeting shared a new approach to increasing the supply of donor corneal tissue: improving blood collection practices. Efforts to expand tissue availability have usually...

Expanded Use of Diabetic Donor Corneas May Help Address Tissue Shortages
Expanded Use of Diabetic Donor Corneas May Help Address Tissue Shortages

The growing prevalence of diabetes among cornea donors within the past decade has heightened concerns about the disease’s potential impact on keratoplasty outcomes and transplant success. Concern a...

Moria Highlights New CAIRS Instruments at 2026 EBAA Meeting
Moria Highlights New CAIRS Instruments at 2026 EBAA Meeting

Jana D’Amato Tothova, PhD, group R&D director at Moria, described for attendees of the “Innovative Solutions Showcase” at the 2026 EBAA meeting the benefits of Moria’s newly developed instruments d...

Everest Acquires Rights in Greater China to Lenz’ Vizz for Presbyopia
Everest Acquires Rights in Greater China to Lenz’ Vizz for Presbyopia

Everest Medicines, of Shanghai, China, has acquired rights in Greater China to Lenz Therapeutics’ Vizz (LNZ100) eye drops for presbyopia, Lenz reported June 7. Lenz, of San Diego, California, said ...

Bausch + Lomb Launches PreserVision AREDS3 Eye Vitamins in the US
Bausch + Lomb Launches PreserVision AREDS3 Eye Vitamins in the US

Bausch + Lomb reported May 19 that it had launched its PreserVision AREDS3 eye vitamins in the US for patients with age-related macular degeneration (AMD) at risk of progression. The supplements co...

Georgia Southern University Gains Funding for State’s First College of Optometry
Georgia Southern University Gains Funding for State’s First College of Optometry

Georgia Southern University announced May 26 that it had received $29.8 million in state funding to establish the first college of optometry in Georgia. The school said the money will support the r...

Clinical Trial Updates for Ophthalmic Candidates, June 2026
Clinical Trial Updates for Ophthalmic Candidates, June 2026

Market Scope is tracking companies that have announced clinical trial updates or milestone achievements.

Outlook Therapeutics Resubmits BLA for Lytenava After Winning FDA Appeal
Outlook Therapeutics Resubmits BLA for Lytenava After Winning FDA Appeal

Outlook Therapeutics reported June 1 that it had resubmitted its biologics license application (BLA) to the US FDA for Lytenava, its ophthalmic formulation of bevacizumab for the treatment of wet a...

Emerging Companies Pursuing Ophthalmic Indications, June 2026
Emerging Companies Pursuing Ophthalmic Indications, June 2026

Market Scope is tracking companies that have announced new candidates to diagnose and treat eye disease.

Weekly Poll of MDs, US Only, June 2026
Weekly Poll of MDs, US Only, June 2026

June 2026 Ophthalmic News Briefs
June 2026 Ophthalmic News Briefs

UK-based Rayner announced June 1 the launch of Ophteis Cohesive, a new OVD formulated with a high molecular weight to optimize space creation and ease of removal. Ophteis Cohesive is packaged at 1....

Everest Acquires Rights in Greater China to Lenz’ Vizz for Presbyopia
Everest Acquires Rights in Greater China to Lenz’ Vizz for Presbyopia

Everest Medicines, of Shanghai, China, has acquired rights in Greater China to Lenz Therapeutics’ Vizz (LNZ100) eye drops for presbyopia, Lenz reported June 7. Lenz, of San Diego, California, said ...

Formycon’s Aflibercept Biosimilar in Prefilled Syringes Now Available in EU
Formycon’s Aflibercept Biosimilar in Prefilled Syringes Now Available in EU

Germany’s Formycon announced May 19 that its aflibercept (Eylea) biosimilar, known in various territories as Ahzantive and Baiama, was now available in the European Union. It is being introduced in...

Samsung Bioepis Launches Aflibercept Biosimilar Branded Opuviz in EU
Samsung Bioepis Launches Aflibercept Biosimilar Branded Opuviz in EU

Korea’s Samsung Bioepis announced May 29 that it had launched Opuviz, a biosimiliar referencing Eylea (aflibercept), across Europe. The biosimilar is also available in Korea and Canada as Aflivu. H...

Harrow Relaunches Verkazia in the US for Vernal Keratoconjunctivitis
Harrow Relaunches Verkazia in the US for Vernal Keratoconjunctivitis

Harrow reported June 10 that it had relaunched Verkazia (cyclosporine ophthalmic emulsion, 0.1%) in the US for the treatment of vernal keratoconjunctivitis (VKC). VKC is a serious allergic eye dise...

AAO Licenses Clinical Practice Guidelines to OpenEvidence Chatbot for Doctors
AAO Licenses Clinical Practice Guidelines to OpenEvidence Chatbot for Doctors

The American Academy of Ophthalmology reported June 9 that it had licensed the guidance in itsPreferred Practice Patterns and Ophthalmic Technology Assessments to OpenEvidence for its medical AI pl...

Apotex Gains Health Canada Approval for Iheezo Ophthalmic Anesthesia
Apotex Gains Health Canada Approval for Iheezo Ophthalmic Anesthesia

Toronto’s Apotex announced May 26 that it had secured Health Canada marketing approval for Iheezo (chloroprocaine hydrochloride ophthalmic gel 3%), a topical anesthetic indicated for ocular surface...

Bausch + Lomb Launches Blink Triple Care Preservative Free Drops in US
Bausch + Lomb Launches Blink Triple Care Preservative Free Drops in US

Bausch + Lomb announced June 1 the US launch of Blink Triple Care Preservative Free eye drops. The lipid- and water-based formula combines a natural oil—to help keep tears from evaporating too quic...

Want to Read Locked Articles?

Register A Corporate Account

A corporate account gives you access to licensed reports and subscriptions, the latest news, a personalized dashboard, and weekly emails with news and data.

Select one or more
Select one or more